A sign of things to come
22 June 2010Genomic technologies developed by A*STAR’s Singapore Immunology Network (SIgN) form the basis for a new vaccine development platform that could pave the way for cost-effective personalized therapy
Inspired by cerebral physiology, scientists at the A*STAR Institute for Infocomm Research are developing a display technology and system that will make it possible to show high dynamic range images on conventional displays based on gaze tracking.